Orient Pharma Co., Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was TWD 132.821 million compared to TWD 117.068 million a year ago. Operating loss was TWD 110.967 million compared to TWD 132.834 million a year ago. Net loss was TWD 84.121 million compared to TWD 67.935 million a year ago. Basic loss per share was TWD 0.54 compared to TWD 0.44 a year ago.